About: Forte Biosciences, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for autoimmune and autoimmune-related diseases. The company offers products, such as its lead product candidate FB102, a proprietary molecule with applications for celiac disease, vitiligo, and alopecia areata; and services, including the clinical development and management of its Phase 2 clinical trials. Forte Biosciences, Inc. was incorporated in 2007 and is based in Dallas, Texas. As of August 27, 2026, Forte Biosciences, Inc. operates as a subsidiary of argenx SE.
Sector: Healthcare
Industry: Biotechnology
Latest price: $76.99 (+0.03%)
Status: deslistada — removed_from_provider. Este ativo não é mais negociado; são exibidos dados históricos.
FBRX NASDAQ Forte Biosciences Inc
Forte Biosciences Inc share price
Atividade de preço de FBRX
Último preço
Variação (24h)
USD
Volume
-
Volume (média 4 sem.)
-
Fechamento anterior
N/D
Último negócio
FBRX price performance
quote.marketSignals